Brian Park, PharmD

Drug Information Specialist https://www.clinicalpainadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Migraine & Headache

Positive Migraine Outcomes Reported With Novel Intranasal Dihydroergotamine

Brian Park, PharmD

June 16, 2020

Positive results were announced from the phase 3 STOP-301 study evaluating INP104 for the treatment of acute migraine in adults.

Neuropathic Pain

Topical Amitriptyline Receives Orphan Drug Designation for Erythromelalgia

Brian Park, PharmD

June 11, 2020

The FDA has granted Orphan Drug designation to ATX01 (proprietary topical amitriptyline; AlgoTherapeutix) for the treatment of erythromelalgia.

Neuropathic Pain

Orphan Drug Status Granted to Anti-MAG Neuropathy Antigen-Specific Therapy

Brian Park, PharmD

June 9, 2020

The FDA has granted Orphan Drug designation to PN-1007 for the treatment of anti-myelin-associated glycoprotein (MAG) neuropathy.

General Pain

Unapproved Cannabidiol Injectables Marketed for Multiple Disorders Recalled

Brian Park, PharmD

May 28, 2020

Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.

General Pain

DEA: 2020 Drugs of Abuse Resource Guide Now Available

Brian Park, PharmD

April 21, 2020

The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.

Musculoskeletal Pain

FDA Approves NDA for OTC Diclofenac Topical Gel for Arthritis Pain

Brian Park, PharmD

April 9, 2020

Perrigo announced that the FDA has approved the abbreviated NDA for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain.

General Pain

Meloxicam Injection Now Available for Managing Moderate to Severe Pain

Brian Park, PharmD

April 9, 2020

The treatment is approved for the management of moderate to severe pain, alone or in combination with non-NSAIDs in adult patients.

Musculoskeletal Pain

Eptinezumab Now Available for Migraine Prevention in Select Pharmacies

Brian Park, PharmD

April 7, 2020

Vyepti™ (eptinezumab-jjmr; Lundbeck) is now available for the preventive treatment of migraine in adults through select specialty distributors and pharmacies.

Migraine & Headache

FDA Clears Hand-Held Vagus Nerve Stimulator for Migraine Prevention

Brian Park, PharmD

April 3, 2020

The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.

Migraine & Headache

Significant Reduction in Monthly Migraine Days With Rimegepant in Prevention Trial

Brian Park, PharmD

April 2, 2020

Biohaven announced positive topline results from a pivotal phase 2/3 study evaluating rimegepant for the preventive treatment of episodic and chronic migraine in adults.

Next post in Migraine & Headache